1 Zonisamide Market Overview 1.1 Product Overview and Scope of Zonisamide 1.2 Zonisamide Segment by Type 1.2.1 Global Zonisamide Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 25mg 1.2.3 50mg 1.2.4 100mg 1.3 Zonisamide Segment by Application 1.3.1 Global Zonisamide Sales Comparison by Application: (2021-2027) 1.3.2 Adult 1.3.3 Pediatric 1.3.4 Geriatric 1.4 Global Zonisamide Market Size Estimates and Forecasts 1.4.1 Global Zonisamide Revenue 2016-2027 1.4.2 Global Zonisamide Sales 2016-2027 1.4.3 Zonisamide Market Size by Region: 2016 Versus 2021 Versus 2027 2 Zonisamide Market Competition by Manufacturers 2.1 Global Zonisamide Sales Market Share by Manufacturers (2016-2021) 2.2 Global Zonisamide Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Zonisamide Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Zonisamide Manufacturing Sites, Area Served, Product Type 2.5 Zonisamide Market Competitive Situation and Trends 2.5.1 Zonisamide Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Zonisamide Players Market Share by Revenue 2.5.3 Global Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Zonisamide Retrospective Market Scenario by Region 3.1 Global Zonisamide Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Zonisamide Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Zonisamide Market Facts & Figures by Country 3.3.1 North America Zonisamide Sales by Country 3.3.2 North America Zonisamide Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Zonisamide Market Facts & Figures by Country 3.4.1 Europe Zonisamide Sales by Country 3.4.2 Europe Zonisamide Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Zonisamide Market Facts & Figures by Region 3.5.1 Asia Pacific Zonisamide Sales by Region 3.5.2 Asia Pacific Zonisamide Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Zonisamide Market Facts & Figures by Country 3.6.1 Latin America Zonisamide Sales by Country 3.6.2 Latin America Zonisamide Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Zonisamide Market Facts & Figures by Country 3.7.1 Middle East and Africa Zonisamide Sales by Country 3.7.2 Middle East and Africa Zonisamide Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Zonisamide Historic Market Analysis by Type 4.1 Global Zonisamide Sales Market Share by Type (2016-2021) 4.2 Global Zonisamide Revenue Market Share by Type (2016-2021) 4.3 Global Zonisamide Price by Type (2016-2021) 5 Global Zonisamide Historic Market Analysis by Application 5.1 Global Zonisamide Sales Market Share by Application (2016-2021) 5.2 Global Zonisamide Revenue Market Share by Application (2016-2021) 5.3 Global Zonisamide Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Concordia 6.1.1 Concordia Corporation Information 6.1.2 Concordia Description and Business Overview 6.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Concordia Zonisamide Product Portfolio 6.1.5 Concordia Recent Developments/Updates 6.2 Eisai 6.2.1 Eisai Corporation Information 6.2.2 Eisai Description and Business Overview 6.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Eisai Zonisamide Product Portfolio 6.2.5 Eisai Recent Developments/Updates 6.3 Zydus Pharmaceuticals 6.3.1 Zydus Pharmaceuticals Corporation Information 6.3.2 Zydus Pharmaceuticals Description and Business Overview 6.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Zydus Pharmaceuticals Zonisamide Product Portfolio 6.3.5 Zydus Pharmaceuticals Recent Developments/Updates 6.4 Sun Pharma 6.4.1 Sun Pharma Corporation Information 6.4.2 Sun Pharma Description and Business Overview 6.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sun Pharma Zonisamide Product Portfolio 6.4.5 Sun Pharma Recent Developments/Updates 6.5 Wockhardt 6.5.1 Wockhardt Corporation Information 6.5.2 Wockhardt Description and Business Overview 6.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Wockhardt Zonisamide Product Portfolio 6.5.5 Wockhardt Recent Developments/Updates 6.6 Mylan 6.6.1 Mylan Corporation Information 6.6.2 Mylan Description and Business Overview 6.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Mylan Zonisamide Product Portfolio 6.6.5 Mylan Recent Developments/Updates 6.7 APOTEX 6.6.1 APOTEX Corporation Information 6.6.2 APOTEX Description and Business Overview 6.6.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.4.4 APOTEX Zonisamide Product Portfolio 6.7.5 APOTEX Recent Developments/Updates 6.8 Teva 6.8.1 Teva Corporation Information 6.8.2 Teva Description and Business Overview 6.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Teva Zonisamide Product Portfolio 6.8.5 Teva Recent Developments/Updates 6.9 Glenmark 6.9.1 Glenmark Corporation Information 6.9.2 Glenmark Description and Business Overview 6.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Glenmark Zonisamide Product Portfolio 6.9.5 Glenmark Recent Developments/Updates 6.10 Bluepharma 6.10.1 Bluepharma Corporation Information 6.10.2 Bluepharma Description and Business Overview 6.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Bluepharma Zonisamide Product Portfolio 6.10.5 Bluepharma Recent Developments/Updates 6.11 Invagen Pharmaceuticals 6.11.1 Invagen Pharmaceuticals Corporation Information 6.11.2 Invagen Pharmaceuticals Zonisamide Description and Business Overview 6.11.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Invagen Pharmaceuticals Zonisamide Product Portfolio 6.11.5 Invagen Pharmaceuticals Recent Developments/Updates 6.12 Intas Pharmaceuticals 6.12.1 Intas Pharmaceuticals Corporation Information 6.12.2 Intas Pharmaceuticals Zonisamide Description and Business Overview 6.12.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Intas Pharmaceuticals Zonisamide Product Portfolio 6.12.5 Intas Pharmaceuticals Recent Developments/Updates 7 Zonisamide Manufacturing Cost Analysis 7.1 Zonisamide Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Zonisamide 7.4 Zonisamide Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Zonisamide Distributors List 8.3 Zonisamide Customers 9 Zonisamide Market Dynamics 9.1 Zonisamide Industry Trends 9.2 Zonisamide Growth Drivers 9.3 Zonisamide Market Challenges 9.4 Zonisamide Market Restraints 10 Global Market Forecast 10.1 Zonisamide Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Zonisamide by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Zonisamide by Type (2022-2027) 10.2 Zonisamide Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Zonisamide by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Zonisamide by Application (2022-2027) 10.3 Zonisamide Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Zonisamide by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Zonisamide by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Zonisamide Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Zonisamide Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Zonisamide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Zonisamide Covered in This Study Table 5. Global Zonisamide Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Zonisamide Sales Market Share by Manufacturers (2016-2021) Table 7. Global Zonisamide Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Zonisamide Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Zonisamide Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Zonisamide Manufacturing Sites and Area Served Table 11. Manufacturers Zonisamide Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Zonisamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zonisamide as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Zonisamide Sales by Region (2016-2021) & (K Units) Table 16. Global Zonisamide Sales Market Share by Region (2016-2021) Table 17. Global Zonisamide Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Zonisamide Sales by Country (2016-2021) & (K Units) Table 19. North America Zonisamide Sales Market Share by Country (2016-2021) Table 20. North America Zonisamide Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Zonisamide Revenue Market Share by Country (2016-2021) Table 22. Europe Zonisamide Sales by Country (2016-2021) & (K Units) Table 23. Europe Zonisamide Sales Market Share by Country (2016-2021) Table 24. Europe Zonisamide Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Zonisamide Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Zonisamide Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Zonisamide Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Zonisamide Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Zonisamide Revenue Market Share by Region (2016-2021) Table 30. Latin America Zonisamide Sales by Country (2016-2021) & (K Units) Table 31. Latin America Zonisamide Sales Market Share by Country (2016-2021) Table 32. Latin America Zonisamide Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Zonisamide Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Zonisamide Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Zonisamide Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Zonisamide Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Zonisamide Revenue Market Share by Country (2016-2021) Table 38. Global Zonisamide Sales (K Units) by Type (2016-2021) Table 39. Global Zonisamide Sales Market Share by Type (2016-2021) Table 40. Global Zonisamide Revenue (Million US$) by Type (2016-2021) Table 41. Global Zonisamide Revenue Share by Type (2016-2021) Table 42. Global Zonisamide Price (USD/Unit) by Type (2016-2021) Table 43. Global Zonisamide Sales (K Units) by Application (2016-2021) Table 44. Global Zonisamide Sales Market Share by Application (2016-2021) Table 45. Global Zonisamide Revenue (Million US$) by Application (2016-2021) Table 46. Global Zonisamide Revenue Share by Application (2016-2021) Table 47. Global Zonisamide Price (USD/Unit) by Application (2016-2021) Table 48. Concordia Corporation Information Table 49. Concordia Description and Business Overview Table 50. Concordia Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Concordia Zonisamide Product Table 52. Concordia Recent Developments/Updates Table 53. Eisai Corporation Information Table 54. Eisai Description and Business Overview Table 55. Eisai Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Eisai Zonisamide Product Table 57. Eisai Recent Developments/Updates Table 58. Zydus Pharmaceuticals Corporation Information Table 59. Zydus Pharmaceuticals Description and Business Overview Table 60. Zydus Pharmaceuticals Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Zydus Pharmaceuticals Zonisamide Product Table 62. Zydus Pharmaceuticals Recent Developments/Updates Table 63. Sun Pharma Corporation Information Table 64. Sun Pharma Description and Business Overview Table 65. Sun Pharma Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Sun Pharma Zonisamide Product Table 67. Sun Pharma Recent Developments/Updates Table 68. Wockhardt Corporation Information Table 69. Wockhardt Description and Business Overview Table 70. Wockhardt Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Wockhardt Zonisamide Product Table 72. Wockhardt Recent Developments/Updates Table 73. Mylan Corporation Information Table 74. Mylan Description and Business Overview Table 75. Mylan Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Mylan Zonisamide Product Table 77. Mylan Recent Developments/Updates Table 78. APOTEX Corporation Information Table 79. APOTEX Description and Business Overview Table 80. APOTEX Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. APOTEX Zonisamide Product Table 82. APOTEX Recent Developments/Updates Table 83. Teva Corporation Information Table 84. Teva Description and Business Overview Table 85. Teva Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Teva Zonisamide Product Table 87. Teva Recent Developments/Updates Table 88. Glenmark Corporation Information Table 89. Glenmark Description and Business Overview Table 90. Glenmark Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Glenmark Zonisamide Product Table 92. Glenmark Recent Developments/Updates Table 93. Bluepharma Corporation Information Table 94. Bluepharma Description and Business Overview Table 95. Bluepharma Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Bluepharma Zonisamide Product Table 97. Bluepharma Recent Developments/Updates Table 98. Invagen Pharmaceuticals Corporation Information Table 99. Invagen Pharmaceuticals Description and Business Overview Table 100. Invagen Pharmaceuticals Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Invagen Pharmaceuticals Zonisamide Product Table 102. Invagen Pharmaceuticals Recent Developments/Updates Table 103. Intas Pharmaceuticals Corporation Information Table 104. Intas Pharmaceuticals Description and Business Overview Table 105. Intas Pharmaceuticals Zonisamide Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. Intas Pharmaceuticals Zonisamide Product Table 107. Intas Pharmaceuticals Recent Developments/Updates Table 108. Production Base and Market Concentration Rate of Raw Material Table 109. Key Suppliers of Raw Materials Table 110. Zonisamide Distributors List Table 111. Zonisamide Customers List Table 112. Zonisamide Market Trends Table 113. Zonisamide Growth Drivers Table 114. Zonisamide Market Challenges Table 115. Zonisamide Market Restraints Table 116. Global Zonisamide Sales Forecast by Type (2022-2027) & (K Units) Table 117. Global Zonisamide Sales Market Share Forecast by Type (2022-2027) Table 118. Global Zonisamide Revenue Forecast by Type (2022-2027) & (US$ Million) Table 119. Global Zonisamide Revenue Market Share Forecast by Type (2022-2027) Table 120. Global Zonisamide Sales Forecast by Application (2022-2027) & (K Units) Table 121. Global Zonisamide Sales Market Share Forecast by Application (2022-2027) Table 122. Global Zonisamide Revenue Forecast by Application (2022-2027) & (US$ Million) Table 123. Global Zonisamide Revenue Market Share Forecast by Application (2022-2027) Table 124. Global Zonisamide Sales Forecast by Region (2022-2027) & (K Units) Table 125. Global Zonisamide Sales Market Share Forecast by Region (2022-2027) Table 126. Global Zonisamide Revenue Forecast by Region (2022-2027) & (US$ Million) Table 127. Global Zonisamide Revenue Market Share Forecast by Region (2022-2027) Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Zonisamide Figure 2. Global Zonisamide Market Share by Type in 2020 & 2027 Figure 3. 25mg Product Picture Figure 4. 50mg Product Picture Figure 5. 100mg Product Picture Figure 6. Global Zonisamide Market Share by Application in 2020 & 2027 Figure 7. Adult Figure 8. Pediatric Figure 9. Geriatric Figure 10. Global Zonisamide Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Zonisamide Market Size 2016-2027 (US$ Million) Figure 12. Global Zonisamide Sales 2016-2027 (K Units) Figure 13. Global Zonisamide Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Zonisamide Sales Share by Manufacturers in 2020 Figure 15. Global Zonisamide Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Zonisamide Players: Market Share by Revenue in 2020 Figure 17. Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Zonisamide Sales Market Share by Region (2016-2021) Figure 19. Global Zonisamide Sales Market Share by Region in 2020 Figure 20. Global Zonisamide Revenue Market Share by Region (2016-2021) Figure 21. Global Zonisamide Revenue Market Share by Region in 2020 Figure 22. U.S. Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Zonisamide Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Zonisamide by Type (2016-2021) Figure 47. Sales Market Share of Zonisamide by Application (2016-2021) Figure 48. Sales Market Share of Zonisamide by Application in 2020 Figure 49. Revenue Share of Zonisamide by Application (2016-2021) Figure 50. Revenue Share of Zonisamide by Application in 2020 Figure 51. Manufacturing Cost Structure of Zonisamide Figure 52. Manufacturing Process Analysis of Zonisamide Figure 53. Zonisamide Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Concordia Eisai Zydus Pharmaceuticals Sun Pharma Wockhardt Mylan APOTEX Teva Glenmark Bluepharma Invagen Pharmaceuticals Intas Pharmaceuticals